The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Association of prior poly(ADP-ribose) polymerase (PARP) inhibitor therapy with response to 177Lu-PSMA-617 (LuPSMA) in men with DNA damage repair (DDR) mutations.
 
Ruben Raychaudhuri
No Relationships to Disclose
 
George Mo
No Relationships to Disclose
 
Abuzar Moradi Tuchayi
No Relationships to Disclose
 
Laura Graham
No Relationships to Disclose
 
Roman Gulati
Employment - Linda Fukuda Family Dentistry (I)
 
Colin C. Pritchard
Consulting or Advisory Role - AstraZeneca; Sana Biotechnology
Research Funding - Color Genomics (I)
 
Michael C. Haffner
Research Funding - Merck
 
Todd Yezefski
Honoraria - Pfizer/Myovant
Consulting or Advisory Role - Dendreon
 
Jessica E. Hawley
Consulting or Advisory Role - Daiichi Sankyo/Lilly; ImmunityBio
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb/Celgene (Inst); Crescendo Biologics (Inst); Macrogenics (Inst); Vaccitech (Inst)
 
Robert Bruce Montgomery
Consulting or Advisory Role - Daiichi Sankyo/UCB Japan
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Beigene (Inst); Clovis Oncology (Inst); Janssen Oncology (Inst)
 
Heather H. Cheng
Consulting or Advisory Role - AstraZeneca; AstraZeneca (I)
Research Funding - Clovis Oncology (Inst); Color Genomics Foundation (Inst); Janssen (Inst); Medivation/Astellas (Inst); Phosplatin Therapeutics (Inst); Sanofi (Inst)
Patents, Royalties, Other Intellectual Property - UpToDate
Other Relationship - Janssen
 
Peter Nelson
Consulting or Advisory Role - Astellas Pharma; Bristol-Myers Squibb; Janssen Oncology; Roche/Genentech
Research Funding - Genomic Health (Inst); Janssen Oncology
Expert Testimony - Venable
Travel, Accommodations, Expenses - Janssen Oncology
 
Delphine L Chen
Honoraria - GE Healthcare; Telix Pharmaceuticals
Research Funding - Telix Pharmaceuticals (Inst)
Patents, Royalties, Other Intellectual Property - WO 201503526 A1 Mach RH, Chu W, Zhou D, Michel LS, Chen DL. Radiolabeled tracers for poly(adp-ribose)polymerase-1 (PARP-1), methods and uses therfor
Travel, Accommodations, Expenses - GE Healthcare
 
Thomas A. Hope
Stock and Other Ownership Interests - Curium Pharma; RayzeBio
Honoraria - GE Healthcare
Consulting or Advisory Role - Bayer; Blue Earth Diagnostics; Curium Pharma; Ipsen; ITM Isotope Technologies Munich; Lantheus Medical Imaging
Research Funding - Advanced Accelerator Applications (Inst); Clovis Oncology (Inst); GE Healthcare (Inst); Janssen Oncology (Inst); Lantheus Medical Imaging (Inst); Philips Healthcare (Inst); Telix Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - GE Healthcare
 
Amir Iravani
No Relationships to Disclose
 
Michael Thomas Schweizer
Consulting or Advisory Role - AstraZeneca; PharmaIn; Sanofi
Research Funding - Ambrx (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Epigenetix (Inst); Incyte (Inst); Janssen (Inst); Madison Vaccines, Inc. (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); SignalOne Bio (Inst); Tmunity Therapeutics, Inc. (Inst); Zenith Epigenetics (Inst)